Bit new to this stock so dug into the ASX filings a bit. As...

Bit new to this stock so dug into the ASX filings a bit. As TinnyVale points out, the notice for the AGM in April 2023 appears to provide quite a fulsome 4 page explanation of the grant of performance rights for the MD/CEO (P15 onwards). The rights are all in accordance with his disclosed salary package and the performance plan which seems to have been in place for some time. The rights appear to be 100% provisional, stretch out to 2025 and subject to meeting performance criteria which are laid out and can be cross checked with the annual report for more detail. It appears that no cash bonuses have been paid recently, conversely CEO and other directors have been taking shares in lieu of salary to support company CF. Being new to this stock, I cant say 100% whether they are deserved, however, it seems this team has led quite a turnaround back to profitability suggested by the last quarterly report? Suggest amb005 and other shareholders read the material released by the company and, if holders of the stock, vote at the AGM if not happy.
DYOR.